Repros Therapeutics Inc Stock

Stocks

18-01-26	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
17-12-15	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
17-12-12	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
17-12-12	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
17-12-12	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

15-04-02	Apple : Les valeurs à suivre sur les marchés américains
15-04-02	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	+1.15%	+1.57%	-12.35%	-11.97%	43.03B
REVOLUTION MEDICINES, INC.	+3.11%	+3.11%	+279.08%	+509.39%	32.71B
IQVIA HOLDINGS INC.	+0.22%	-1.08%	+15.66%	-14.70%	30.29B
BEONE MEDICINES AG	+1.62%	-2.08%	-1.91%	+27.08%	29.4B
CELLTRION, INC.	+4.09%	+0.93%	+12.97%	+20.66%	25.08B
ASCENDIS PHARMA A/S	+1.14%	+3.62%	-	-	13.54B
MEDPACE HOLDINGS, INC.	-1.63%	+2.88%	+56.69%	+114.08%	13.35B
EUROFINS SCIENTIFIC SE	+0.62%	-0.62%	+5.29%	+6.83%	12.97B
IONIS PHARMACEUTICALS, INC.	-0.74%	-1.62%	+105.89%	+79.51%	12.11B
Average	+0.96%	+1.45%	+57.67%	+91.36%	23.61B
Weighted average by Cap.	+1.42%	+1.48%	+57.55%	+98.48%